| scholarly article | Q13442814 |
| P2093 | author name string | B I HOFFBRAND | |
| E R BECK | |||
| P2860 | cites work | Steroid therapy in pulmonary fibroses | Q78507377 |
| Pulmonary lesions in disseminated lupus erythematosus | Q78573116 | ||
| Pleuropulmonary Manifestations in Lupus Erythematosus Disseminatus | Q78844374 | ||
| Inability to form a lung-lining film as a cause of the respiratory-distress syndrome in the newborn | Q79048687 | ||
| Maximum forced expiratory flow rate as a measure of ventilatory capacity: with a description of a new portable instrument for measuring it | Q24681831 | ||
| Pulmonary changes in disseminated lupus erythematosus | Q33570382 | ||
| Normal standards for lung volumes, intrapulmonary gas-mixing, and maximum breathing capacity | Q33602967 | ||
| Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. | Q35230924 | ||
| An assessment of the steady-state carbon monoxide method of estimating pulmonary diffusing capacity | Q41978441 | ||
| Lung function in patients with systemic sclerosis | Q42161004 | ||
| The effect of the rate of breathing on the maximum breathing capacity determined with a new spirometer | Q42162424 | ||
| Chronic diffuse interstitial pulmonary fibrosis and rheumatoid arthritis. | Q51292335 | ||
| Clinical Use of Peak Flow Meter | Q54985155 | ||
| Obliterative pulmonary hypertension and thromboembolism. | Q55009704 | ||
| Lipoprotein Composition of the Film lining the Lung | Q59053296 | ||
| Simple rapid methods of estimating arterial and mixed venous pCO2. | Q64943468 | ||
| Visceral lesions in disseminated lupus erythematosus | Q73002775 | ||
| The pulmonary manifestations of disseminated lupus erythematosus | Q73283234 | ||
| IMPAIRED OXYGENATION IN SURGICAL PATIENTS DURING GENERAL ANESTHESIA WITH CONTROLLED VENTILATION. A CONCEPT OF ATELECTASIS | Q76549605 | ||
| PULMONARY DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS | Q77113640 | ||
| Pleuritis in systemic lupus erythematosus: its importance as an early manifestation in diagnosis | Q77189057 | ||
| The lungs as an index of systemic disease | Q78346881 | ||
| P433 | issue | 5445 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 1273-1277 | |
| P577 | publication date | 1965-05-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | "UNEXPLAINED" DYSPNOEA AND SHRINKING LUNGS IN SYSTEMIC LUPUS ERYTHEMATOSUS. | |
| P478 | volume | 1 |
| Q36756226 | Acute Lung Changes in Rheumatoid Arthritis |
| Q69472540 | Acute Lupus Pneumonitis: Response to Azathioprine Therapy |
| Q49375001 | Cardiopulmonary Manifestations of Collagen Vascular Diseases |
| Q71246323 | Design, dynamics and deduction: a radiologist looks at the human lung |
| Q67063004 | Diaphragm function and lung involvement in systemic lupus erythematosus |
| Q42777899 | Diaphragmatic weakness and myositis associated with systemic juvenile rheumatoid arthritis. |
| Q36811025 | Diffuse pulmonary fibrosis and bilateral pneumothoraces in systemic lupus erythematosus |
| Q68735312 | Drug-induced lung disease |
| Q69402807 | Mixed connective tissue disease |
| Q39424460 | Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs. |
| Q34085066 | Possible association of "shrinking lung" and anti-Ro/SSA antibody |
| Q70758840 | Pulmonary Function Abnormalities in Systemic Lupus Erythematosus Responsive to Glucocorticoid Therapy |
| Q69366828 | Pulmonary fibrosis. Etiology, Pathophysiology, Diagnosis (author's transl) |
| Q77903286 | Pulmonary manifestations of systemic lupus erythematosus |
| Q39817683 | Pulmonary manifestations of the rheumatic diseases |
| Q36999306 | Pulmonary renal syndromes--a review. |
| Q40265664 | Pulmonary renal syndromes. II. Etiology and pathogenesis |
| Q83816583 | Reinforcing a medical hypothesis with a new question: is there a subgroup of shrinking lungs syndrome that is induced by pleurisy in systemic lupus erythematosus and is this subgroup marked by anti-Ro/SSA? |
| Q36269545 | Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens |
| Q68515108 | Respiratory diseases |
| Q66885995 | Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study |
| Q68410506 | Serial Pulmonary Function Testing in Patients with Systemic Lupus Erythematosus |
| Q33723612 | Severe cognitive dysfunction and shrinking lung syndrome in systemic lupus erythematous |
| Q34532551 | Shrinking lung syndrome |
| Q30585011 | Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies |
| Q42116485 | Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap |
| Q37726793 | Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature |
| Q38038100 | Shrinking lung syndrome masked by pleuropericarditis: a case report and review of the literature |
| Q70781020 | Systemic lupus erythematosus |
| Q34990070 | Systemic lupus erythematosus in the intensive care unit |
| Q72285352 | The "shrinking lung syndrome" in SLE, treatment with theophylline |
| Q35392146 | Vanishing syndromes |
| Q67823941 | [Pleuropulmonary manifestations of systemic lupus erythematosus] |
| Q84600757 | [Systemic lupus erythematosus. Infrequent clinical aspects] |
Search more.